These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8643525)

  • 1. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
    Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of Huntington's disease.
    Walling HW; Baldassare JJ; Westfall TC
    J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts.
    Nagao Y; Ishiguro H; Nukina N
    Biochim Biophys Acta; 2000 Oct; 1502(2):247-56. PubMed ID: 11040449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
    Zainelli GM; Ross CA; Troncoso JC; Fitzgerald JK; Muma NA
    J Neurosci; 2004 Feb; 24(8):1954-61. PubMed ID: 14985437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
    Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
    FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin.
    Dudek NL; Dai Y; Muma NA
    Brain Pathol; 2010 Jan; 20(1):176-89. PubMed ID: 19338577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Huntington's disease (IT15) protein product in HD patients.
    Schilling G; Sharp AH; Loev SJ; Wagster MV; Li SH; Stine OC; Ross CA
    Hum Mol Genet; 1995 Aug; 4(8):1365-71. PubMed ID: 7581375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Huntington disease protein with transcriptional activator Sp1.
    Li SH; Cheng AL; Zhou H; Lam S; Rao M; Li H; Li XJ
    Mol Cell Biol; 2002 Mar; 22(5):1277-87. PubMed ID: 11839795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease gene product, huntingtin, associates with microtubules in vitro.
    Tukamoto T; Nukina N; Ide K; Kanazawa I
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):8-14. PubMed ID: 9427501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.
    Hackam AS; Singaraja R; Zhang T; Gan L; Hayden MR
    Hum Mol Genet; 1999 Jan; 8(1):25-33. PubMed ID: 9887328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential distribution of the normal and mutated forms of huntingtin in the human brain.
    Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel JL; Hirsch EC
    Ann Neurol; 1997 Nov; 42(5):712-9. PubMed ID: 9392570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.
    Li SH; Li XJ
    Hum Mol Genet; 1998 May; 7(5):777-82. PubMed ID: 9536080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R; Atwal RS; Burtnik A
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains.
    Modregger J; DiProspero NA; Charles V; Tagle DA; Plomann M
    Hum Mol Genet; 2002 Oct; 11(21):2547-58. PubMed ID: 12354780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Huntington disease. A review].
    Bonilla E
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.